Get the Stockscreener App
6.30
0.16%
-0.010
After Hours:
6.19
-0.11
-1.75%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc Stock (BHC) Forecast
The Bausch Health Companies Inc (BHC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.252, representing a -32.51% decrease from the current price of $6.30. The highest analyst price target is $6.8385, and the lowest is $1.6655.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BHC Price Target
Average 7.0702
(+12.23% Upside)
Is Bausch Health Companies Inc (BHC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 61.27 | Neutral |
| STOCH(9,6) | 60.28 | Neutral |
| STOCHRSI(14) | 97.72 | Sell |
| MACD(12,26) | 0.0398 | Buy |
| ADX(14) | 15.43 | Neutral |
| William %R | -10.90 | Sell |
| CCI(14) | 142.02 | Buy |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.046
Buy
|
6.0505
Buy
|
| MA20 |
5.8945
Buy
|
5.9961
Buy
|
| MA50 |
6.1618
Buy
|
5.941
Buy
|
| MA100 |
5.6264
Buy
|
5.8299
Buy
|
| MA200 |
5.7294
Buy
|
5.8812
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, BHC could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on BHC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 61.27 indicates that BHC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 60.28 indicates that BHC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 97.72 indicates that BHC is oversold. This suggests that BHC price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.43 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 142.02 indicates that BHC is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term BHC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bausch Health Companies Inc financial reports and earnings history, Bausch Health Companies Inc (BHC) stock could reach $6.5061 by 2030, $42.11 by 2040 and $91.49 by 2050. See the projected annual prices until 2050 of the Bausch Health Companies Inc stock below:
- Bausch Health Companies Inc (BHC) is expected to reach an average price of $20.36 in 2035, with a high prediction of $20.62 and a low estimate of $20.86. This indicates an $223.13% rise from the last recorded price of $6.30.
- Bausch Health Companies Inc (BHC) stock is projected to chart a bullish course in 2040, with an average price target of $39.30, representing an $523.87% surge from its current level. The forecast ranges from a conservative $40.59 to a sky-high $42.11.
- Our analysts predict Bausch Health Companies Inc (BHC) to jump 949.50% by 2045, soaring from $66.29 to an average price of $66.12, potentially reaching $66.76. While $66.29 is the low estimate, the potential upside is significant.
- Bausch Health Companies Inc (BHC) stock is expected to climb by 2050, reaching an average of $91.76, a $1,357% jump from its current level. However, a wide range of estimates exists, with high and low targets of $91.49 and $84.61, respectively, highlighting the market's uncertainty.
Bausch Health Companies Inc Stock (BHC) Year by Year Forecast
Bausch Health Companies Inc Stock (BHC) Price Forecast for 2026
The predicted value for Bausch Health Companies Inc (BHC) in 2026 is set at an average of $4.5024. Estimates vary from a peak of $8.00 to a trough of $1.0047, indicating an -28.53% surge from the present price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.7955 | $1.6655 | $6.8385 | -71.50% |
| December, 2026 | $6.1824 | $1.0047 | $6.3818 | -1.87% |
Bausch Health Companies Inc Stock (BHC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bausch Health Companies Inc (BHC) is $7.0702, with a high forecast of $13.94 and a low forecast of $0.2049. This indicates an +12.23% increase from the last price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4894 | $3.0494 | $6.6017 | -44.61% |
| February, 2027 | $3.7964 | $0.7837 | $5.0514 | -39.74% |
| March, 2027 | $1.2826 | $0.2049 | $4.5506 | -79.64% |
| April, 2027 | $2.2396 | $0.8718 | $3.3161 | -64.45% |
| May, 2027 | $4.4642 | $0.3073 | $3.2288 | -29.14% |
| June, 2027 | $10.55 | $10.77 | $10.35 | +67.42% |
| July, 2027 | $11.28 | $11.14 | $12.13 | +79.05% |
| August, 2027 | $10.96 | $11.15 | $11.38 | +74.03% |
| September, 2027 | $14.05 | $14.08 | $13.94 | +122.97% |
| October, 2027 | $11.86 | $13.40 | $13.78 | +88.26% |
| November, 2027 | $12.51 | $12.29 | $12.00 | +98.63% |
| December, 2027 | $11.71 | $12.36 | $12.04 | +85.82% |
Bausch Health Companies Inc Stock (BHC) Price Forecast for 2028
In 2028, Bausch Health Companies Inc (BHC) is projected to reach an average price of $9.2016, with a high projection of $11.75 and a low estimate of $6.6544. This indicates an +46.06% rise from the last price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.50 | $11.42 | $11.11 | +66.68% |
| February, 2028 | $11.91 | $11.24 | $11.75 | +89.11% |
| March, 2028 | $9.5767 | $9.8867 | $10.57 | +52.01% |
| April, 2028 | $8.2098 | $10.29 | $9.8238 | +30.31% |
| May, 2028 | $9.8235 | $8.4363 | $9.2035 | +55.93% |
| June, 2028 | $9.6966 | $9.9366 | $9.4466 | +53.91% |
| July, 2028 | $8.5904 | $9.7573 | $10.91 | +36.35% |
| August, 2028 | $9.4634 | $8.6876 | $8.5269 | +50.21% |
| September, 2028 | $8.0764 | $8.9664 | $9.0491 | +28.20% |
| October, 2028 | $7.0602 | $6.6544 | $7.4272 | +12.07% |
| November, 2028 | $7.5432 | $7.7132 | $7.4617 | +19.73% |
| December, 2028 | $7.4262 | $7.2655 | $7.274 | +17.88% |
Bausch Health Companies Inc Stock (BHC) Price Forecast for 2029
The 2029 price forecast for Bausch Health Companies Inc Stock (BHC) is $6.1331 on average, with a high prediction of $8.4608 and a low estimate of $3.8054. This represents an -2.65% decrease from the previous price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.78 | $7.5869 | $8.06 | +39.37% |
| February, 2029 | $8.213 | $8.4723 | $8.4608 | +30.37% |
| March, 2029 | $7.5761 | $7.8353 | $7.8188 | +20.26% |
| April, 2029 | $6.0499 | $6.4999 | $7.1576 | -3.97% |
| May, 2029 | $6.4229 | $6.5199 | $6.2729 | +1.95% |
| June, 2029 | $4.7159 | $5.2809 | $5.9836 | -25.14% |
| July, 2029 | $3.1997 | $4.3397 | $4.5032 | -49.21% |
| August, 2029 | $4.8627 | $3.8054 | $4.7527 | -22.81% |
| September, 2029 | $6.5657 | $4.7735 | $6.0357 | +4.22% |
| October, 2029 | $6.2395 | $6.8395 | $6.6473 | -0.96% |
| November, 2029 | $5.2026 | $5.5426 | $5.9803 | -17.42% |
| December, 2029 | $6.7763 | $6.9291 | $6.9856 | +7.56% |
Bausch Health Companies Inc Stock (BHC) Price Forecast for 2030
Bausch Health Companies Inc Stock (BHC) is expected to reach an average price of $4.5061 in 2030, with a high forecast of $6.5061 and a low forecast of $2.5062. This signifies an -28.47% decrease from the last price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.9494 | $6.2394 | $6.5061 | -5.57% |
| February, 2030 | $3.7124 | $4.0224 | $3.8759 | -41.07% |
| March, 2030 | $2.5954 | $3.7454 | $3.6481 | -58.80% |
| April, 2030 | $3.1292 | $2.5062 | $3.0484 | -50.33% |
| May, 2030 | $3.6122 | $3.7399 | $3.4972 | -42.66% |
| June, 2030 | $3.5852 | $3.3645 | $3.2252 | -43.09% |
| July, 2030 | $3.419 | $3.6518 | $4.3383 | -45.73% |
| August, 2030 | $3.3321 | $3.5821 | $3.2721 | -47.11% |
| September, 2030 | $5.0958 | $3.9828 | $4.9308 | -19.11% |
| October, 2030 | $5.3689 | $4.9573 | $4.6566 | -14.78% |
| November, 2030 | $4.9619 | $5.31 | $5.0911 | -21.24% |
| December, 2030 | $2.3657 | $2.8357 | $3.6226 | -62.45% |
1.46%
4.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):